about
mission / vision
our team
board members
executive leadership
scientists
careers
postdoctoral programs
internship programs
current job opportunities
| |
David P. Perry
David Perry has served on IDRI’s Board of Directors since February of 2009. He is currently the President and Chief Executive Officer of Anacor Pharmaceuticals, a biopharmaceutical company working to develop novel small-molecule therapeutics derived from its boron chemistry platform to treat infectious and inflammatory diseases. David also co-founded the biotechnology company Virogen in 1995, and founded the business-to-business market place company Chemdex Corporation in 1997. David holds a BS from the University of Tulsa, and received his MBA from Harvard University.
|
|
